India · Delayed Price · Currency is INR Artemis Medicare Services Statistics
Total Valuation
NSE:ARTEMISMED has a market cap or net worth of INR 34.03 billion. The enterprise value is 33.04 billion.
| Market Cap | 34.03B |
| Enterprise Value | 33.04B |
Important Dates
The next estimated earnings date is Friday, August 8, 2025.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Jul 11, 2025 |
Share Statistics
NSE:ARTEMISMED has 138.93 million shares outstanding. The number of shares has increased by 11.81% in one year.
| Current Share Class | 138.93M |
| Shares Outstanding | 138.93M |
| Shares Change (YoY) | +11.81% |
| Shares Change (QoQ) | +0.67% |
| Owned by Insiders (%) | 2.50% |
| Owned by Institutions (%) | 2.07% |
| Float | 26.53M |
Valuation Ratios
The trailing PE ratio is 46.12 and the forward PE ratio is 32.23.
| PE Ratio | 46.12 |
| Forward PE | 32.23 |
| PS Ratio | 3.63 |
| PB Ratio | 4.03 |
| P/TBV Ratio | 4.33 |
| P/FCF Ratio | 64.86 |
| P/OCF Ratio | 23.37 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.85, with an EV/FCF ratio of 62.97.
| EV / Earnings | 39.98 |
| EV / Sales | 3.53 |
| EV / EBITDA | 21.85 |
| EV / EBIT | 30.56 |
| EV / FCF | 62.97 |
Financial Position
The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.34.
| Current Ratio | 2.49 |
| Quick Ratio | 2.40 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 1.92 |
| Debt / FCF | 5.53 |
| Interest Coverage | 3.79 |
Financial Efficiency
Return on equity (ROE) is 12.66% and return on invested capital (ROIC) is 7.08%.
| Return on Equity (ROE) | 12.66% |
| Return on Assets (ROA) | 5.80% |
| Return on Invested Capital (ROIC) | 7.08% |
| Return on Capital Employed (ROCE) | 9.47% |
| Revenue Per Employee | 4.51M |
| Profits Per Employee | 397,813 |
| Employee Count | 2,077 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 73.70 |
Taxes
In the past 12 months, NSE:ARTEMISMED has paid 254.90 million in taxes.
| Income Tax | 254.90M |
| Effective Tax Rate | 23.67% |
Stock Price Statistics
The stock price has decreased by -7.14% in the last 52 weeks. The beta is 0.19, so NSE:ARTEMISMED's price volatility has been lower than the market average.
| Beta (5Y) | 0.19 |
| 52-Week Price Change | -7.14% |
| 50-Day Moving Average | 254.82 |
| 200-Day Moving Average | 276.92 |
| Relative Strength Index (RSI) | 47.88 |
| Average Volume (20 Days) | 89,415 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:ARTEMISMED had revenue of INR 9.37 billion and earned 826.26 million in profits. Earnings per share was 5.31.
| Revenue | 9.37B |
| Gross Profit | 1.98B |
| Operating Income | 1.08B |
| Pretax Income | 1.08B |
| Net Income | 826.26M |
| EBITDA | 1.44B |
| EBIT | 1.08B |
| Earnings Per Share (EPS) | 5.31 |
Balance Sheet
The company has 3.95 billion in cash and 2.90 billion in debt, giving a net cash position of 1.05 billion or 7.55 per share.
| Cash & Cash Equivalents | 3.95B |
| Total Debt | 2.90B |
| Net Cash | 1.05B |
| Net Cash Per Share | 7.55 |
| Equity (Book Value) | 8.44B |
| Book Value Per Share | 60.88 |
| Working Capital | 3.23B |
Cash Flow
In the last 12 months, operating cash flow was 1.46 billion and capital expenditures -931.51 million, giving a free cash flow of 524.65 million.
| Operating Cash Flow | 1.46B |
| Capital Expenditures | -931.51M |
| Free Cash Flow | 524.65M |
| FCF Per Share | 3.78 |
Margins
Gross margin is 21.10%, with operating and profit margins of 11.54% and 8.82%.
| Gross Margin | 21.10% |
| Operating Margin | 11.54% |
| Pretax Margin | 11.49% |
| Profit Margin | 8.82% |
| EBITDA Margin | 15.35% |
| EBIT Margin | 11.54% |
| FCF Margin | 5.60% |
Dividends & Yields
This stock pays an annual dividend of 0.45, which amounts to a dividend yield of 0.19%.
| Dividend Per Share | 0.45 |
| Dividend Yield | 0.19% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 8.47% |
| Buyback Yield | -11.81% |
| Shareholder Yield | -11.62% |
| Earnings Yield | 2.43% |
| FCF Yield | 1.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 23, 2021. It was a forward split with a ratio of 10.
| Last Split Date | Sep 23, 2021 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
NSE:ARTEMISMED has an Altman Z-Score of 5.59 and a Piotroski F-Score of 7.
| Altman Z-Score | 5.59 |
| Piotroski F-Score | 7 |